Jay Oza
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- DNA Repair Mechanisms 4
- Heat shock proteins research 2
- Oncology 7
- PARP inhibition in cancer therapy 3
- Co-authors
- Shridar Ganesan (5 shared papers)Vasudeva Ginjala (3 shared papers)Atul Kulkarni (3 shared papers)Ming Yao (2 shared papers)Maarten van Lohuizen (1 shared paper)Sarah J. Hill (1 shared paper)Karim Nacerddine (1 shared paper)Elisabetta Citterio (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Journal of Biological Chemistry (2 papers)BMC Systems Biology (1 paper)Clinical Cancer Research (1 paper)Brain Research (1 paper)
- Partner nations
- United StatesNetherlandsSweden
In The Last Decade
Jay Oza
14 papers receiving 599 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 156
- Aging 14
- Molecular Biology 436
- Oncology 111
- Pulmonary and Respiratory Medicine 73
Countries citing papers authored by Jay Oza
This map shows the geographic impact of Jay Oza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Oza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Oza more than expected).
Fields of papers citing papers by Jay Oza
This network shows the impact of papers produced by Jay Oza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Oza. The network helps show where Jay Oza may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay Oza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 209 | |
| 2 | 2010 | 204 | |
| 3 | 2013 | 58 | |
| 4 | 2008 | 34 | |
| 5 | 2020 | 29 | |
| 6 | 2008 | 25 | |
| 7 | 2016 | 12 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 5 | |
| 11 | 2019 | 5 | |
| 12 | 2021 | 3 | |
| 13 | 2022 | 1 | |
| 14 | 2011 | 1 |
About Jay Oza
Jay Oza is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 14 papers that have together received 603 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), DNA Repair Mechanisms (4 papers), PARP inhibition in cancer therapy (3 papers), Heat shock proteins research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), thermodynamics and calorimetric analyses (2 papers), Acute Myeloid Leukemia Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (156 citations), Aging (14 citations), Molecular Biology (436 citations), Oncology (111 citations) and Pulmonary and Respiratory Medicine (73 citations). Jay Oza has collaborated with scholars based in United States, Netherlands and Sweden. Frequent co-authors include Shridar Ganesan, Vasudeva Ginjala, Atul Kulkarni, Ming Yao, Maarten van Lohuizen, Sarah J. Hill, Karim Nacerddine, Elisabetta Citterio, Anupama Reddy and W. Kimryn Rathmell. Their work appears in journals such as Journal of Clinical Oncology, Journal of Biological Chemistry, BMC Systems Biology, Clinical Cancer Research and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.